On May 27, Citizens JMP lowered the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) to $29 from $78 but kept an Outperform rating on the shares. The notable price target decrease came ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results